Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational, Retrospective Study to Evaluate the Long Term Safety and Effectiveness of Leuprorelin in the Treatment of Central Precocious Puberty

NCT02993926 is registered in ClinicalTrials.gov with Takeda as lead sponsor.

NCT NCT02993926
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02993926 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational, Retrospective Study to Evaluate the Long Term Safety and Effectiveness of Leuprorelin in the Treatment of Central Precocious Puberty
Lead sponsor
Takeda
Phase
Observational
Overall status
Completed
Start date
June 24, 2017
Completion date
September 30, 2018
Enrollment
108 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

central precocious puberty